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Abstract
Osteoarthritis (OA) is a common, painful and debilitating disease of articulating joints resulting from the age-associated loss of
cartilage. Well-powered genetic studies have identified a number of DNA polymorphisms that are associated with OA
susceptibility. Like most complex trait loci, these OA loci are thought to influence disease susceptibility through the regulation
of gene expression, so-called expression quantitative loci, or eQTLs. Onemechanism throughwhich eQTLs act is epigenetic, by
modulating DNAmethylation. In such cases, there are quantitative differences in DNAmethylation between the two alleles of
the causal polymorphism, with the association signal referred to as a methylation quantitative trait locus, or meQTL. In this
study, we aimed to investigate whether the OA susceptibility loci identified to date are functioning as meQTLs by integrating
genotype data with whole genome methylation data of cartilage DNA. We investigated potential genotype–methylation
correlations within a 1.0–1.5 Mb region surrounding each of 16 OA-associated single-nucleotide polymorphisms (SNPs) in 99
cartilage samples and identified four that function as meQTLs. Three of these replicated in an additional cohort of up to 62 OA
patients. These observations suggest that OA susceptibility loci regulate the level of DNA methylation in cis and provide a
mechanistic explanation as to how these loci impact uponOA susceptibility, further increasing our understanding of the role of
genetics and epigenetics in this common disease.
Introduction
Osteoarthritis (OA) is characterized by the age-related gradual
thinning and eventual focal loss of articular cartilage and as
such is a painful disease that severely impacts on normal joint
function (1,2). There are no disease-modifying pharmacological
therapies for OA, with pain management and joint replacement
the principal clinical treatments. As a result, the health economic
burden of the disease is large and will increase with a progres-
sively ageing population.
OA is polygenic and a number of candidate gene and genome-
wide association scan (GWAS) studies have reported OA risk-
conferring loci for knee, hip or hand OA that exceed or are close
to the genome-wide significance threshold (3–14). While some of
the signals encompass genes with prior known roles in joint
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biology, most do not. In addition, many of the signals demon-
strate association only in the knee, or the hip, or the hand rather
than across all tested skeletal sites. Furthermore, some signals
are restricted to a particular sex, an example being the associ-
ation signal marked by the intergenic single-nucleotide poly-
morphism (SNP) rs10948172, which is only relevant to OA in
males (11). Stratification by joint site and sex has therefore pro-
ven critical in identifying OA association signals (3).
A recurring feature of the GWAS data derived for common
polygenic traits is that the majority of association signals do
not alter gene-coding sequences but rather are located within
non-coding or intergenic regions. It is assumed therefore that
the polymorphisms are within regulatory elements and influ-
ence the trait by altering gene expression. Such loci are referred
to as expression quantitative trait loci, or eQTLs (15). Examples
in OA are the association signals marked by SNPs rs143383,
rs4730250 and rs225014, which show correlationwith the expres-
sion of the genes GDF5, HBP1 and DIO2, respectively (5,16–19).
These studies support a growing consensus that OA susceptibil-
ity loci act through regulating gene expression.
It is becoming increasingly apparent that epigenetics also has
a prominent role in OA pathogenesis. For example, candidate
studies have demonstrated that several genes involved in cartil-
age homeostasis are differentially methylated in OA (20–22),
whilemore genome-wide approaches usingDNAmethylation ar-
rays have highlighted compelling epigenetic alterations asso-
ciated with the disease (23–27).
The relationship between DNA sequence variants and DNA
methylation has generated a large amount of interest in recent
years, and it is now well established that SNPs can influence
the level of methylation at proximal CpG sites. Such SNPs are re-
ferred to as methylation quantitative trait loci or meQTLs. The
identification of meQTLs can help in the interpretation of non-
coding genetic risk alleles, potentially identifying novel dis-
ease-associated candidate genes in which methylation acts as a
mediator between genotype and phenotype. This approach has
been successfully utilized in a number of conditions, including
neurological disorders, cancer, rheumatoid arthritis and meta-
bolic traits (28–32). meQTLs are common in the human genome,
with methylation levels of 28.5% of CpGs associated with nearby
SNPs in adipose tissue (32) while 10.7% of type II diabetes risk
SNPs are meQTLs (33). A specific example is the adipose-specific
meQTL located in an enhancer region upstream of the metabolic
disease-associated geneADCY3. Two CpG siteswithin this region
correlatewith the genotype of the bodymass index SNP rs713586.
Between these two CpG sites is a SNP in perfect (r2 = 1) linkage
disequilibrium (LD) with rs713586 that overlaps a binding site
for USF1, a transcription factor that regulates genes involved in
lipid and glucose homeostasis (32). In OA, evidence of interplay
between genetics and epigenetics has been reported for the func-
tional SNP rs143383, with its effect on GDF5 expression being
modulated by DNA methylation (34,35), and for the DIO2 SNP
rs225014 (36).
In this study, we aimed to investigate all of the OA association
signals reported to date to assesswhich, if any, are functioning as
meQTLs. We focussed on cartilage, the tissue central to the OA
disease process. Cartilage contains only a single cell type, the
chondrocyte, which in the context of epigenetic studies is an ad-
vantage in that it limits the scope for confounding heterogeneity
that can be encountered if studying the epigenetics of amulticel-
lular tissue in which cell-specific effects are likely. To identify
meQTLs, we combined genotyping data with genome-wide
methylation data from the cartilage of 99 patients, 63 of whom
had knee OA, 17 with hip OA and 19 that had a neck of femur
(NOF) fracture and who are free of OA. In total, we assessed 16
SNPs representing 16 loci that have been reported to be asso-
ciated with OA.
Results
Identification of OA meQTLs
Genome-wide methylation was measured using our previously
published data (24) using the Illumina Infinium HumanMethyla-
tion450 BeadChip. This array, which captures over 450 000 CpGs,
will henceforth be referred to as the 450k array. For each of the 16
loci, we covered at least the whole of the LD region; therefore, for
15 loci we spanned 1 Mb while for the rs10948172 locus we
spanned 1.5 Mb. Table 1 lists the loci and the number of CpG
probes from the 450k array that were assessed at each locus
for genotype–methylation correlations. Initially, we assessed
correlations in all samples combined—OA knee, OA hip and
NOF. This analysis identified four SNPs that correlated with
methylation (Benjamin–Hochberg P < 0.05): chromosome 3p21.1
(GLT8D1), SNP rs6976 and three CpGs; chromosome 6p21.1
(SUPT3H), SNP rs10948172 and four CpGs; chromosome 15q21.3
(ALDH1A2), SNP rs3204689 and one CpG; and chromosome
20q11 (GDF5), SNP rs143383 and one CpG (Table 2). Patient infor-
mation and genotypes at the four SNPs are shown in Supplemen-
tary Material, Table S1. For each of these nine CpGs, we next
compared themethylation levels without genotype stratification
but stratified by OA knee, OA hip and NOF. This revealed that the
degree of methylation was on average significantly lower in
the NOF patients for the 3p21.1 (GLT8D1, rs6976) and 6p21.1
(SUPT3H, rs10948172) CpGs, but that there was no difference be-
tween OA knee and OA hip (data not shown). We therefore re-
peated the analysis for all 16 loci separating OA from NOF. This
analysis of only OA samples identified the same four SNPs and
no OA-specific or NOF-specific genotype–methylation correla-
tions (Table 2). As mentioned previously, many OA genetic asso-
ciation signals were only discovered following stratification by
joint and/or sex. When we repeated our analysis using such
stratification, we did not identify any further genotype–methyla-
tion correlations. In summary, we identified four potential
meQTLs, and these are summarized in Table 2 and discussed in
more detail below.
Genotype at GLT8D1 SNP rs6976 correlated with the methyla-
tion of three CpGs located ∼31.5 kb upstream of the LD block and
∼170 kb from the SNP: cg18099408, cg15147215 and cg18591801.
All three CpGs are within the gene body of STAB1 (Fig. 1A), and
for each CpG, the OA-associated T allele of rs6976 correlated
with lower methylation (Fig. 1B; data for the OA patients only
shown). Significant correlationswere seenwhen all of the patient
samples were combined (OA knee, OA hip and NOF) as well as in
OA samples alone (Table 2).
Genotype at the SUPT3H SNP rs10948172 correlated with the
methylation of four adjacent CpGs located ∼82 kb upstream from
the SNP: cg13979708, cg19254793, cg20913747 and cg18551225. All
fourare locatedwithin the LD regionmarked by rs10948172,which
encompasses a ∼667 kb region from hg19 chromosome 6:44 683
049–45 349 877 (Fig. 2A). These four CpG sites are 650 kb down-
stream of the SUPT3H transcription start site (TSS) (Fig. 2A), and
for each, the OA-associated G allele of rs10948172 correlated
with lower methylation (Fig. 2B; data for the OA patients only
shown). rs10948172 is associated with OA in males but not in fe-
males (11). However, the meQTL was operating in both males
and females (Supplementary Material, Fig. S1), although there is
reduced methylation of cg13979708, cg20913747 and cg18551225
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in males independent of rs10948172 genotype (Supplementary
Material, Fig. S1A, C and D). The meQTL was observed for all of
the patient samples combined and in OA samples alone (Table 2).
TheOA-associatedC allele of theALDH1A2 SNP rs3204689 cor-
related with lower methylation at the CpG cg12031962, which is
located 107 kb from the SNP (Fig. 3A). This CpG is within the
gene body of ALDH1A2 and within the OA susceptibility region.
This meQTL was observed when all of the patient samples were
combined (Fig. 3B) and in OA samples only (Table 2).
Genotype at GDF5 SNP rs143383 correlated with methylation
at one CpG, cg14752227, which is located 25 kb from the SNP,
0.5 kb upstream of the TSS of UQCC and 25 kb upstream of the
TSS of GDF5 (Fig. 3C). This CpG site resides within the rs143383
LD region and is located 17 bp downstream of the rs62210592
SNP, which has an r2 of 0.92 with rs143383. The OA-associated
T allele of rs143383 correlated with lower methylation of
cg14752227 (Fig. 3D; data for all patients shown). This effect was
observed for all of the patient samples combined and in OA sam-
ples only (Table 2).
Replication of OA meQTLs
Having identified four OA-associated SNPs correlating with
methylation at nine CpG sites, we next attempted to replicate
these findings in cartilage DNA samples from additional pa-
tients. This replication cohort consisted of 40 OA patients (26
knee and 14 hip) and 5 NOF patients (Supplementary Material,
Table S1). As noted above, for rs6976 and rs10948172, significant
differences in methylation levels were observed in the discovery
study between OA and NOF patients. We therefore excluded the
five NOF samples in the replication analysis of these two SNPs.
DNA methylation was measured by pyrosequencing. We were
unable to design reliable pyrosequencing assays for cg15147215
and cg18591801, both from the chromosome 3p21.1 locus
(GLT8D1, rs6976), but this left cg18099408 from this locus. In
total, therefore, replication assays were designed to cover the re-
maining seven discovery CpGs. In the design of these assays,
seven additional CpGs that were not on the 450k array but
which are in close proximity to one or more of the seven discov-
ery CpGs were also captured. These were therefore included in
Table 2. List of significant genotype-methylation associations identified
SNP CpG probe Chr. Probe location (hg19) SNP location (hg19) Adj. P-value All samples Adj. P-value OA
rs6976 cg18099408
cg15147215
cg18591801
3p21.1 52552593
52552868
52553433
52728804 3.19 × 10−8
0.005
0.004
3.73 × 10−6
0.04
0.04
rs10948172 cg13979708
cg19254793
cg20913747
cg18551225
6p21.1 44695318
44695348
44695427
44695536
44777691 9.83 × 10−6
0.008
8.75 × 10−13
1.70 × 10−10
6.2 × 10−5
0.009
4.9 × 10−12
1.12 × 10−10
rs3204689 cg12031962 15q21.3 58353849 58246802 1.03 × 10−10 2.0 × 10−8
rs143383 cg14752227 20q11 34000481 34025983 0.001 0.01
Shown are the P-values from all of the samples combined and OA samples only. Adj. P-value represents the Benjamini–Hochberg corrected P-value.
Table 1. List of the 16 OA association signals studied
Locus Association
SNP
Major/minor
allele
Position
(hg19)
Chr. Nearest
gene
Proxy SNP Stratum References Number of CpG
probes from
the 450k array
1 rs6976 C/T 52703844 3 GLT8D1 – Knees and hips 11 431
2 rs12107036 G/A 191082854 3 TP63 – Female knees 11 76
3 rs10948172 A/G 44885669 6 SUPT3H – Males 11 197
4 rs9350591 C/T 76298247 6 FILIP1 rs7756065 Hips 11 157
5 rs3815148 A/C 106938420 7 COG5 rs1548524 Knees 8 135
6 rs4836732 T/C 118306516 9 ASTN2 – Female hips 11 57
7 rs10492367 G/T 27906237 12 KLHDC5 rs10843013 Hips 11 123
8 rs835487 A/G 103584897 12 CHST11 – Hips 11 190
9 rs11842874 A/G 113694259 13 MCF2L – Knees and hips 10 655
10 rs225014 T/C 80669330 14 DIO2 – Hips 7 32
11 rs945006 T/G 102029277 14 DIO3 – Knees and hips 9 385
12 rs3204689 C/G 58246802 15 ALDH1A2 – Hands 13 91
13 rs8044769 C/T 53839135 16 FTO – Females 11 92
14 rs12982744 C/G 2177193 19 DOT1L – Male hips 12 135
15 rs6094710 G/A 46095649 20 NCOA3 – Hips 14 71
16 rs143383 T/C 34025983 20 GDF5 rs6087704 Knees and hips 4,5 270
Stratum highlights the joint and/or sex that the signal shows association with from the original genetic study. The number of CpG probes from the 450k array that is
present within the 1 Mb region (1.5 Mb for rs10948172) surrounding the association SNP are shown. In the discovery analysis, 90 of the 99 patients had their genotypes
at the 16 SNPs determined using data from the HumanOmniExpress array. For SNPs not present on the array, a proxy SNP that had the highest linkage disequilibrium (LD)
with the association SNP and which was on the array was used to infer genotypes. This was necessary for four SNPs; for three of these (rs9350591, rs3815148 and
rs10492367), the proxy SNP is in perfect LD (r2 = 1) with the association SNP while for rs143383, the proxy SNP has an r2 of 0.93.
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our analysis, such that in total we analysed 14 CpGs, the 7 to be
replicated plus an additional 7.
The GLT8D1 rs6976 discovery CpG site cg18099408 replicated
in the cohort of 40 OA patients in the same direction as in the dis-
covery cohort (P = 0.0029; Fig. 4A). Two additional CpG sites lo-
cated 5 and 9 bp downstream from cg18099408 were captured
by the pyrosequencing assay; these CpG sites also demonstrated
significant correlation between rs6976 genotype and methyla-
tion, and in the same direction as cg18099408 (Fig. 4B and C).
All four discovery CpGs within the rs10948172 SUPT3H
meQTL region replicated in the additional cohort, with the OA-
associated G allele again correlating with lower methylation
(Fig. 5B–E). Additionally, three further CpG sites were captured
by the pyrosequencing assays, the first located 3 bp upstream
of cg13979708, and the other two located 7 and 11 bp down-
stream of cg18551225. All three additional CpG sites demon-
strated significant correlation between rs10948172 genotype
and methylation (Fig. 5A, F and G), and in the same direction
as that seen for the four discovery CpGs. This replication analysis
of rs10948172 included an additional 17 OA knee patient samples
(Supplementary Material, Table S1) that were included to en-
hance our power to detect any gender differences inmethylation
independently of genotype at this male-specific susceptibility
locus, making a total of 57 OA patient samples (34 females and
23 males). As with the discovery cohort, the effect of rs10948172
genotype on methylation of the seven CpG sites within the
meQTL region was observed in both males and females (data not
shown), even though the OA genetic risk at this locus is male
specific.
The effect of theALDH1A2 rs3204689 SNP genotype onmethy-
lation of the cg12031962 CpG was also observed in the additional
cohort of 45 cartilage samples (P < 0.0001; Fig. 6A, left graph). Add-
itionally, the OA-associated C allele of rs3204689 correlated with
reduced methylation of another CpG site captured by the assay
that is located 12 bp downstream of cg12031962 (P = 0.0002;
Fig. 6A, right graph).
The effect of the GDF5 rs143383 SNP genotype onmethylation
of cg14752227 was observed in the replication cohort of 45 pa-
tients, although this was not significant (Fig. 6B, left graph).
This assay captured an additional CpG site located 38 bp away
from cg14752227, which also demonstrated a non-significant
trend in the same direction as that seen for cg14752227 (Fig. 6B,
right graph).
In summary, six of the seven discovery CpGs replicated
(P < 0.05), and in the same direction as seen previously. Five of
the seven additional CpGs captured by the assays also demon-
strated a significant correlation between genotype and methyla-
tion and in the same direction as their respective discovery CpGs.
Figure 1.Genotype at rs6976 correlateswith themethylation levels at threeCpG siteswithin the gene bodyof STAB1. (A) The plot shows the association between rs6976 and
the methylation levels of CpG probes that are present within the LD block. The x-axis represents the genomic position of the CpG probes, and the y-axis represents the
Benjamini–Hochberg corrected −log10 P-value of the correlation between rs6976 genotype and β-value at each CpG probe. Each open circle represents a single CpG probe,
and the three significant associations are labelled (cg15147215 and cg18591801 have the same P-value and on the x-axis scale used are represented by a single open circle).
The LD block is indicated by the vertical dotted lines and the location of rs6976 by the bold dashed line. The genes within the region analysed are indicated below the
association plot, with the gene direction indicated by arrows. (B) The association between genotype at rs6976 and methylation levels at the three significant CpG
probes. Due to the significant methylation differences at these CpGs between OA and NOF samples, data are shown only for the 80 OA samples from the discovery
cohort of 99 samples. The level of methylation at the CpG probes is shown as the β-value. Horizontal line represents the mean.
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Three of the four OA meQTLs therefore replicated, while the
GDF5 meQTL demonstrated a non-significant trend towards
replication.
The impact of OA meQTLs on gene expression
We next assessed whether the meQTLs correlated with gene ex-
pression. For 29 of the 63 OA knee patients used in the discovery
phase of our meQTL analysis, we had RNA available from the
same cartilage samples. For the four meQTL loci, we assayed
the expression of 11 genes that are known to be expressed in car-
tilage (4,5,11,13,37). For each gene, we correlated the expression
level with the methylation level for each discovery CpG from
that mQTL locus. For example, for the rs6976 locus, a correlation
between expression for each of the six cartilage-expressed genes
and the level of methylation at each of the three discovery CpGs
(cg18099408, cg15147215 and cg18591801) was made.
None of the genes showed a significant correlation (P < 0.05;
Spearman correlation) between gene expression and methyla-
tion, or between expression and genotype (Fig. 7; Supplementary
Material, Figs S2 and S3). We did, however, observe a non-signifi-
cant trend between ALDH1A2 expression and genotype at
rs3204689 (P = 0.088; Fig. 7A), with the risk-conferring C allele cor-
relatingwith reduced expression; this fits with the previous eQTL
analysis of this locus in OA cartilage (13). There was also a non-
significant positive correlation between ALDH1A2 expression
and cg12031962 methylation in OA knee cartilage (Fig. 7B).
Analysis of OA meQTLs in other cell and tissue types
We next analysed published studies that used the 450k array to
determine whether any of the cartilage meQTLs that we had
identified were also active in other cell or tissues types. This re-
vealed that each of our cartilage meQTLs operate as meQTLs in
non-joint tissues, with the SUPT3H/RUNX2 cg20913747 and the
ALDH1A2 cg12031962 signals demonstrating the most wide-
spread effects, with meQTL activity in at least six cell/tissue
types (Table 3). To assess whether these two meQTLs also oper-
ate in non-cartilaginous joint tissues fromOApatients, we exam-
ined methylation at these sites in DNA extracted from the
synovium and infrapatellar fat pad of OA knee patients. We
also analysed whole-blood DNA from OA knee patients.
For the SUPT3H/RUNX2 rs10948172meQTL,we investigated the
CpG cg20913747, which is subject to an rs10948172 meQTL in
seven tissues in the published reports (Table 3). Furthermore,
this CpG site showed the most significant effects in our cartilage
data (Figs 2B and 5D), with genotype accounting for 27.8 and
24.6%of the total inter-individual variability in cg20913747methy-
lation in the discovery and replication cohorts, respectively.
Although overall methylation was lower in synovium and
fat pad than in cartilage, we observed a significant effect of
rs10948172 genotype oncg20913747methylation in all three tissue
types in the same direction as in cartilage (Fig. 8A); rs10948172
genotype accounted for 63.1, 14.1 and 6.7% of cg20913747 methy-
lation variability in synovium, fat pad and blood, respectively. For
Figure 2. Genotype at rs10948172 correlates with the methylation levels at four CpG sites located downstream of SUPT3H. (A) The plot shows the association between
rs10948172 genotype and the methylation levels of CpG probes that are present within the LD block. The x-axis represents the genomic position of the CpG probes,
and the y-axis represents the Benjamini–Hochberg corrected –log10 P-value of the correlation between rs10948172 genotype and each CpG probe β-value. Each open
circle represents a single CpG probe, the genomic location of rs10948172 is indicated by a bold dashed line, and the LD block is indicated by the vertical dotted lines.
The location of the SUPT3H and RUNX2 genes is indicated by arrows. (B) The association between genotype at rs10948172 and methylation levels at the four significant
CpG probes. Due to the significant methylation differences at these CpGs between OA and NOF samples, data are shown only for the 80 OA samples from the discovery
cohort of 99 samples. The level of methylation at the CpG probes is shown as the β-value. Horizontal line represents the mean.
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synovium and fat pad, this meQTL was independent of gender
(SupplementaryMaterial, Fig. S4B), althoughwe observed a reduc-
tion in fat pad methylation in males relative to females that was
independent of genotype (P = 0.009; Supplementary Material,
Fig. S4). There is a non-significant decrease in methylation of
cg20913747 in whole blood from males (Supplementary Material,
Fig. S4A), and the effect of rs10948172 genotype on methylation
appears to bemale specific in this tissue (SupplementaryMaterial,
Figure 3. Genotypes at rs3204689 and rs143383 (rs6087704*) correlate with the methylation levels of the cg12031962 and cg14752227 CpG sites, respectively. (A). (C) Plots
show the association between theOA-associated SNPand themethylation levels of CpGprobes that arepresentwithin each LD block for that SNP. The genomic position of
the CpG probes analysed is plotted on the x-axis, and the Benjamini–Hochberg corrected –log10 P-value of the correlation between the genotype and the CpG probe β-value
plotted on the y-axis. Each open circle represents a single CpG probe, and the significant associations are indicated. The genomic location of the OA-associated SNP is
indicated by the bold dashed line, and the LD block is indicated by the vertical dotted lines. The genes within the region analysed are indicated below the association
plot by arrows. (B), (D) Graphs of the association between genotype and methylation β-values for (B) rs3204689-cg12031962 and (D) rs143383-cg14752227. For rs3204689
and rs143383, data are shown for all 99 samples. Horizontal line represents the mean. *rs143383 is not present on the HumanOmniExpress genotyping array and
rs6087704, an array SNP that has the highest LD with rs143383 (r2 = 0.93), was therefore used to infer rs143383 genotypes.
Figure 4. Replication of the association between rs6976 and DNA methylation at cg18099408. (A–C) Plots show the association between genotype at rs6976 and the
methylation levels at three CpGs measured by the pyrosequencing assay; (A) the discovery CpG cg18099408, (B) the CpG site located 5 bp downstream of cg18099408
and (C) the CpG site located 9 bp downstream of cg18099408. Data are shown for the 40 OA samples analysed. P-value was calculated using a Kruskal–Wallis test and
was Bonferroni-corrected for multiple testing. Horizontal line represents the mean.
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Fig. S4B). This, combined with the small effect size observed in
blood relative to synovium and fat pad, may explain why this
meQTL was not identified in other studies of whole blood (31,32).
Analysis of whole blood, synovium and fat pad DNA revealed
thatmethylation levels of theALDH1A2 CpG site cg12031962 vary
between tissues, with the lowest methylation observed in whole
blood (mean of 41.2%, n = 33) and the highest methylation ob-
served in fat pad (mean of 61.6%, n = 31). Despite these differences
in methylation levels, the rs3204689-cg12031962 meQTL is pre-
sent in all three tissues (Fig. 8B) and in the same direction as
seen in cartilage, with the OA-associated C allele of rs3204689
being associated with lower methylation relative to the G allele.
Discussion
Weaimed to investigatewhether OA-associated loci impact upon
DNAmethylation in cartilage in cis and are therefore functioning
as meQTLs. Four of the 16 loci that we tested demonstrated
meQTL activity in the discovery phase, and three demonstrated
statistically significant replication. As far as we are aware, this
is the first study to identify OA association signals operating as
meQTLs. Going forward, the identification and analysis of
meQTLs will be a powerful tool in interpreting the functional
effect of OA risk alleles. Three replicated meQTLs from a total
of 16 loci analysed represent a 18.7% frequency of OA risk loci act-
ing as meQTLs. This figure is comparable to the 10.7% of type II
diabetes loci that also act as meQTLs (33).
We investigated methylation changes that occur within and
immediately adjacent to the LD block of each association signal,
and therefore, our search was focussed on cis-meQTLs. While
there is compelling evidence for the existence of trans-acting
meQTLs operating in common polygenic diseases, to date it has
been observed that the overwhelming majority of meQTLs oper-
ate in cis. These cis affects can act over a range of distances, froma
few base pairs to distances of over 500 kb, with the affected CpG
site being outside of the meQTL SNP LD region (40,41). This is the
case for theGLT8D1 rs6976meQTL, where the three CpGs affected
by genotype at this SNP are located ∼31.5 kb upstream of the
rs6976 LD region. This suggests physical interaction between
the association interval andCpGs nearby but outside of the LD re-
gion. Further to this, there is evidence that proximal CpG sites
may mediate the effect of trans-meQTLs on more distal CpG
sites (41). Although prioritising cis-meQTLs is therefore justified,
we cannot rule out the presence of trans-acting meQTLs operat-
ing on OA association signals. However, trans-meQTLs have
been shown to typically have a smaller effect size than cis-
meQTLs, and their discovery would therefore likely require larger
sample sizes than those in our study.
Although we observed that 4 of the 16 loci are functioning as
cis-meQTLs, we are unable to discount the possibility that the re-
maining 12 also act through the cis-regulation of DNA methyla-
tion. For example, several of the OA associations are hip
specific, and it may be that their effects are only active in hip car-
tilage and that our relatively low number of such samples lacked
power. Furthermore, themethylation array thatweused captures
<5% of the CpGs in the human genome and as such it could miss
effects at other CpGs. Our study therefore provides impetus to
both analyse an even larger data set and to expand the number
of CpGs investigated. For example, our previous analysis of the
5′ untranslated region (UTR) of GDF5 identified several CpG
Figure 5. Replication of the association between rs10948172 and DNA methylation. (A–G) Graphs show the association between genotype at rs10948172 and the
methylation levels at seven CpGs measured by pyrosequencing; the four discovery CpGs (B, cg13979708; C, cg19254793; D, cg20913747 and E, cg18551225) and the three
additional CpG sites captured by the assays located (A) 3 bp upstream of cg13979708, (F) 7 bp downstreamof cg18551225 and (G) 11 bp downstream of cg18551225. Data are
shown for the 57 OA samples studied. P-valuewas calculated using a Kruskal–Wallis test andwas Bonferroni-corrected formultiple testing. Horizontal line represents the
mean.
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Table 3. Cartilage meQTLs active in non-joint tissues
Chromosome 3p21.1 Chromosome 6p21.1 Chromosome 15q21.3 Chromosome 20q11
GNL3/GLT8D1 SUPT3H/RUNX2 ALDH1A2 UQCC/GDF5
rs6976 rs10948172 rs3204689 rs143383
cg15147215 cg19254793 cg20913747 cg18551225 cg12031962 cg14752227
Pancretic islets (33; r2 = 0.72) Pancreatic islets (33) Pancreatic islets (33) Pancreatic islets (33)
Lymphocytes (38; r2 = 0.96) Lymphocytes (38) Lymphocytes (38; r2 = 0.89)
Adipose (32; r2 = 0.78) Adipose (32; r2 = 0.96) Adipose (32) Adipose (32; r2 = 0.92)
Whole blood (32; r2 = 0.96) Whole blood (32) Whole blood (32; r2 = 0.92)
Fibroblasts (39; r2 = 0.96) Fibroblasts (39; r2 = 0.96) Fibroblasts (39; r2 = 0.94)
T lymphocytes (39,40; r2 = 0.96) T lymphocytes (39,40; r2 = 0.94)
Lymphoblastoid (39; r2 = 0.94)
Whole blood (31)
Lung (41; r2 = 0.92) Lung (41; r2 = 0.92)
Whole blood from 247 donors (31). Adipose tissue from 648 donors and peripheral blood from 200 donors (32). Pancreatic islets from 89 donors (33). Lymphocytes from 989 donors with colon cancer and 850 controls (38). Umbilical cord
fibroblasts from 107 donors, T-cells from 66 donors and transformed lymphoblastoid cells from 111 donors (39,40). Lung tissue from 210 donors (41). PublishedmeQTL data sets generated using the 450k array were interrogated for the
four cartilage meQTLs identified in this study (references are indicated in brackets). If the SNP used in a published report is not the same as that used by us (or is a different SNP, which is not in perfect LD with the OA SNP), then its r2
value relative to the OA SNP is shown.
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All four of the cartilagemeQTLs that we discovered have been
previously reported to be operating as meQTLs in other tissues.
This observation is consistent with a previous study that showed
that while DNA methylation patterns are highly tissue specific,
meQTLs can operate across numerous tissues as well as during
different development stages (42). We directly tested two of our
meQTLs, the SUPT3H/RUNX2 rs10948172-cg20913747 meQTL
and the ALDH1A2 rs3204689-cg12031962 meQTL, in other joint
tissues and whole blood from OA knee patients. Even though
methylation levels at these two CpG sites varied between cartil-
age, blood, synovium and fat pad, the effect of genotype on
methylation was observed in all four tissues. However, for the
rs10948172-cg20913747 meQTL, gender also had an effect on
methylation in cartilage, blood and fat pad. In blood, the meQTL
was only present in males, with no effect of rs10948172 genotype
observed in females. In contrast, themeQTLwas observed in both
genders in cartilage and fat pad, although there is reduced
methylation of cg20913747 in males relative to females inde-
pendently of rs10948172 genotype in both tissues. The effect of
gender on cg20913747 is of note given that the OA risk conferred
by the SUPT3H/RUNX2 SNP rs10948172 is male specific, and that
the OA risk G allele is associated with reduced methylation of
cg20913747.
In our study,we stratifiedmethylation by genotype only at the
OA-associated SNPs identified in previous genetic studies; al-
though these SNPs themselves may not be the causal OA risk
SNP, they act as a marker of the OA susceptibility LD block. We
did not stratify the methylation data by genotype of other SNPs
within the analysed regions. We cannot therefore rule out the
possibility that additional SNPs, either those in high LD or not
in LD with the OA SNPs, act as meQTLs on the identified CpG
sites, and that these SNPs may actually drive the meQTLs that
we detected. However, the published meQTL studies of other tis-
sues that we analysed used a genome-wide approach to identify
meQTLs, and in these studies, only the most significant meQTL
for each CpG site was reported. For the cartilage meQTLs identi-
fied in our study that were present in these other tissues, the
SNPs that had the most significant effect on methylation in
these tissues had an r2 of between 0.72 and 1 with the OA-asso-
ciated SNP used in our study. For the meQTLs that are present in
the largest number of tissues, the SUPT3H/RUNX2 rs10948172-
cg20913747 and the ALDH1A2 rs3204689-cg12031962 meQTLs,
the most significant SNPs identified in the genome-wide
meQTL studies had an r2 of between 0.92 and 1 with the OA
SNP. Assuming that the SNP responsible for the meQTL is the
same in all tissues, this suggests that the four cartilage meQTLs
we identified are driven by SNPs in high or perfect LD with the
OA-associated SNPs that we used in our study rather than
being driven by other SNPs within the analysed regions that are
not in LD with the OA susceptibility SNPs.
The effect of methylation on gene expression is well de-
scribed, and it is therefore reasonable to expect that genetic var-
iants that impact onDNAmethylationwould also impact on gene
expression. For example, 6% of adipose meQTLs are also asso-
ciated with gene expression in adipose tissue (32), while causal
inference testing (CIT) has identified 10 CpG sites that mediate
genetic risk for RA through effects on gene expression (31). How-
ever, none of the fourmeQTLs thatwe identified had a significant
effect on gene expression in cartilage. This could be because they
are not functional, or because any expression effects are too
Figure 8.meQTLanalysis of rs10948172-cg20913747 and rs3204689-cg12031962 inwhole blood, synoviumand fat pad fromOAkneepatients. (A) Methylation at cg20913747
stratified by genotype at the SUPT3H/RUNX2 OA SNP rs10948172. (B) Methylation at cg12031962 stratified by genotype at the ALDH1A2 OA SNP rs3204689. The P-value was
calculated using a Kruskal–Wallis test and was Bonferroni-corrected for multiple testing. Horizontal line represents the mean.
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small for us to have detected with our sample size of 29 patients.
It iswell known that regulatory regions are functional only during
specific points of cellular differentiation and tissue formation
(43). It may therefore be that the methylation signatures for the
meQTLs that we detected are enduring markers of an effect on
gene expression that occurred earlier in the development of the
cartilage tissue. For example, they may have influenced the ex-
pression of nearby genes, which led to altered protein levels,
which impacted detrimentally on tissue integrity but which
onlymanifested as a pathology as the individual aged.Wedid ob-
serve that genotype at rs3204689 showed a non-significant trend
with gene expression ofALDH1A2. The association of rs3204689 is
with hand but not with hip or knee OA (13). However, the group
that reported that association signal used hip and knee cartilage
to assess the functional impact of the association signal on
ALDH1A2 expression. This was presumably because of the lack
of cartilage tissue available from the finger joints of OA patients,
which are not typically operated upon. They discovered that the
risk-conferring C allele of rs3204689 is expressed at a lower level
than the G allele. Our ALDH1A2 expression data support this
finding and reiterate that for functional analyses, one can use
cartilage from a skeletal site that does not genetically associate
with OA.
Although DNA methylation has historically been studied in
the context of gene repression, recent studies have identified
other potential roles of DNA methylation in regulating inter-
genic/cryptic start sites, splicing and as a biomarker of histone
modifications and transcription factor binding (reviewed in Ref.
44). DNA methylation levels can act as a marker to distinguish
exons from introns, with methylation being more abundant in
exons relative to the flanking introns, and with methylation le-
vels being higher in constitutively spliced exons than alternative-
ly spliced exons (reviewed in Ref. 45). Several gene-specific and
genome-wide studies in different species have connected DNA
methylation to the regulation of alternative splicing, one ex-
ample being the demethylation-associated changes in alterna-
tive splicing observed in honey bees after inhibition of the
Dnmt3 DNA methyltransferase (46). DNA methylation has also
been implicated in the regulation of alternative promoters, with
tissue-specific DNA methylation of two intragenic promoters
within the human SHANK3 gene inversely correlating with tran-
scription from these alterative promoters in vitro and in vivo (47).
Additionally, in the brain, unmethylated intragenic CpG islands
overlap with the histone modification H3K4me, a marker of ac-
tive promoters, suggesting that they may function as alternative
promoters (47). Both the rs6976-cg15147215 and rs3204689-
cg12031962 meQTLs are located intragenically and so may affect
alternative splicing or transcription from alternative promoters,
neither of which would have been detected by our gene expres-
sion assays. Future RNA-seq-based expression analyses of cartil-
age would be able to address these possibilities.
For all fourmeQTLs,we observed themethylation effectwhen
only OA cartilage samples were analysed and when the OA and
the non-OA NOF samples were combined. This suggests that
the effect of genotype on methylation is not disease driven.
This fits with the polygenic model of common disease aetiology
and confirms the validity of using non-diseased tissues when as-
sessing the effect of a risk-conferring locus (48).
In our study, we specifically focussed on the relationship be-
tween DNA methylation and SNPs that have been reported to be
associatedwith OA at a high degree of statistical significance. In a
previous report on the DNAmethylation of OA cartilage, den Hol-
lander and colleagues (49) correlated global gene expression with
DNA methylation between cartilages located at and away from
the OA lesion. They identified 70 genes that showed both expres-
sion andmethylation differences between the two types of cartil-
age, and for 23 of these 70 genes, proximal SNPs, located within
10 kb of the genes, were found to correlate with expression/
methylation levels. None of these SNPs arewithin the OA associ-
ation signals studied by us. This study, therefore, highlights an
alternative means of identifying meQTLs that could impact on
OA pathology.
In conclusion, we have identified the firstmeQTLs that correl-
ate with OA genetic association signals. These were detected in
cartilage, confirming the important role of this tissue in the dis-
ease process, while two of themwere also observed in other joint
tissues from OA patients, emphasizing the fact that effects on
non-cartilaginous tissue also need to be considered when study-
ing themolecular pathology of OA (50). Furthermore, themeQTLs
are active in non-joint tissues and as such are not OA specific.
The identification of OA meQTLs greatly assists our interpret-
ation of OA susceptibility by demonstrating a functional link
between genetics and epigenetics for this common, age-related
disease.
Materials and Methods
Nucleic acid extraction from patient tissues
Patientswere ascertained and their tissues collected as described
in our previous publications (5,16,24). The Newcastle and North
Tyneside research ethics committee granted ethical approval
for the tissue collection (REC reference number 09/H0906/72),
and informed consent was obtained from each donor. Genomic
DNAwas isolated from ground cartilage, synovium or infrapatel-
lar fat pad using an EZNA DNA/RNA isolation kit (Omega
Bio-Tek), as previously described (24). DNA was extracted from
peripheral whole blood using the QIAamp DNA blood mini kit
(Qiagen). For genotyping, the DNA was used directly, whereas
for methylation analysis, the DNA was bisulphite converted
using the EZ DNA methylation kit (Zymo Research). RNA was
isolated from the ground cartilage using the RNeasy kit (Qiagen),
treated with Turbo DNase (Ambion) and then reverse transcribed
using the SuperScript First-Strand cDNA synthesis kit
(Invitrogen).
Genotyping the 16 SNPs in the discovery data set
We investigated 16 SNPs that have previously been shown to be
associated with OA (Table 1; 4–14). Genotypes were determined
using a genotyping array, a pyrosequencing assay or restriction
fragment length polymorphism (RFLP) analysis (Supplementary
Material, Table S2).
We investigated 99 patients in our discovery of the OA
meQTLs. For 90 of these patients, genotypes at the 16 SNPs
were determined using data from the HumanOmniExpress
Bead Chip array (Illumina). Standard quality control (QC) proce-
dures were carried out in PLINK version 1.07 with visualization
performed in R (http://www.r-project.org/, accessed 26 October
2015) (51). For the remaining nine discovery patients, genotypes
at the 16 SNPs were determined using pyrosequencing or RFLP
assays. Supplementary Material, Table S2 provides details of
the assays, including the sequences of the primers used. An inde-
pendent cohort of cartilage from 62 patients were examined to
replicate the four meQTLs. Genotypes for the four relevant
SNPs (rs6976, rs10948172, rs3204689 and rs143383) were deter-
mined in these patients using pyrosequencing or RFLP assays.
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Discovery of meQTLs
Processed and normalized cartilage DNA methylation data were
acquired from our previous study (24), in which we had used Illu-
mina’s Infinium HumanMethylation450 BeadChip. For each CpG
probe, the data from the array are represented as a β-value that
ranges from 0 (no methylation) to 1 (100% methylation). CpGs
within the entire LD block (defined as r2 > 0.8 with the association
SNP) of each of the 16 SNPswere tested. For 15 of the OA loci, 1 Mb
encompassed the LD block while for rs10948172, the region of
analysis was increased to 1.5 Mb to cover its LD block. Poly-
morphic CpG sites (i.e. those created by a SNP) were excluded
from our analysis. Linear regression was used to measure the re-
lationship between the β-value and the genotype at the OA asso-
ciation SNP. β-Values were modelled as a linear function of the
number of minor alleles (0, 1 or 2), as has been previously re-
ported (42,52). P-values were corrected for multiple testing
using the Benjamini–Hochberg method and were adjusted for
the total numberof CpG probes thatwerewithin the tested region
surrounding the association SNP (Table 1). For example, the 1 Mb
region surrounding rs11842874 (Locus 9) contained 655 CpG
probes and so the correction was made for 655 tests. Genotype–
methylation correlationswere deemed to be significant at P < 0.05
after Benjamini–Hochberg correction.
Replication of meQTLs in cartilage, whole blood,
synovium and fat pad
CpG methylation analysis of the replication cohort was per-
formed by pyrosequencing. The assays were designed using
PyroMark assay design SW 2.0 (Qiagen), and sequencing was per-
formed using PyroMark Q24 (Qiagen) as previously described (34).
The pyrosequencing primer sequences are listed in Supplemen-
tary Material, Table S3. For each sample, PCR reactions were
formed in duplicate and the mean calculated, with samples
being excluded from the analysis if the methylation between
the PCR replicates differed by >5%. For each CpG site analysed,
a Kruskal–Wallis testwith Bonferroni correction formultiple test-
ing was performed using GraphPad Prism software, and geno-
type–methylation correlations were deemed significant if the
adjusted P-value was <0.05. Percentage methylation variability
accounted for by genotype was calculated using a general uni-
variate linear model with the SPSS Statistics software.
Gene expression
Relative gene expression was measured by real-time PCR using
TaqMan® chemistry. Predesigned TaqMan® assays (Integrated
DNA technologies) covering all known transcript variants were
used. Expression of target genes was measured relative to the
housekeeping genes 18S, GAPDH and HPRT1. The relative expres-
sion of the target genes was calculated using the 2−ΔCt method:
2−ΔCt (target gene) = 2 –[Ct (target gene) –Ct (average of housekeeping genes)].
Outliers were removed using the Grubb’s test, and a t-test was
used to assess the differences in gene expression.
Supplementary Material
Supplementary material is available at HMG online.
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